Home
Lynx1 Capital Management reported a 15.2% stake in GH Research GHRS · 9,456,622 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 15.2%
- Last report
- 16.8% · filed 26/02/17
- Shares held
- 9,456,622 sh
- Class
- Ordinary Shares, nominal value $0.025 per share
- Stock
- GH Research GHRS
- Holder
- Lynx1 Capital Management
- Event date
- 26/03/31
- Filed
- 26/05/15
15.2% stake · −1.6pp from the last report
- Stake
- 15.2%
- Last report
- 16.8%
- Since last report
- −1.6pp
GH Research trades, last 26 weeks
What else happened in GH Research around then
Filed or reported within 30 days of the trade day · 03/01~04/30Lynx1 Capital Management's other 5% stake reports
- Lynx1 Capital Management
5% stakeTScan Therapeutics
5% stakeTScan Therapeutics
TCRX
13.1% stake
20,519,148 sh
13.1% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeStoke Therapeutics
5% stakeStoke Therapeutics
STOK
6.5% stake
4,038,404 sh
6.5% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeC4 Therapeutics
5% stakeC4 Therapeutics
CCCC
9.99% stake
15,423,691 sh
9.99% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeiBio
5% stakeiBio
IBIO
5.4% stake
2,807,016 sh
5.4% stake
Filed 08/14
- Lynx1 Capital Management
5% stakeGH Research
5% stakeGH Research
GHRS
19.3% stake
13,263,288 sh
19.3% stake
Filed 08/14
